Higher Self - Hasler, Gregor
20,99 €
inkl. MwSt.

Erscheint vorauss. 2. November 2025
Melden Sie sich für den Produktalarm an, um über die Verfügbarkeit des Produkts informiert zu werden.

payback
10 °P sammeln
  • Broschiertes Buch

Psychedelic therapy is becoming more accessible, with FDA approvals and legalization efforts underway. Higher Self introduces the reader to psychedelics in therapy, combining neuroscience, clinical psychology, and spirituality, while addressing neuroplasticity, mystical experiences, and practical therapeutic insights for laypeople, professionals, and spiritual seekers.

Andere Kunden interessierten sich auch für
Produktbeschreibung
Psychedelic therapy is becoming more accessible, with FDA approvals and legalization efforts underway. Higher Self introduces the reader to psychedelics in therapy, combining neuroscience, clinical psychology, and spirituality, while addressing neuroplasticity, mystical experiences, and practical therapeutic insights for laypeople, professionals, and spiritual seekers.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Gregor Hasler, M.D. was born in Basel, Switzerland. He studied medicine at the University of Zurich and did his psychiatric residency in Paris, London, Lausanne and Zurich, before receiving his medical degree in 1995. Professor Jules Angst of Zurich trained him in psychiatric epidemiology. From 2003 to 2006, he was a visiting scientist at the Mood and Anxiety Disorders Program of the National Institute of Mental Health, specializing in molecular neuroimaging. Since 2010, he has been a full professor of psychiatry at the University of Bern and Chief Medical Officer at the Psychiatric University Hospital of Bern. As of January 2019, he became a full professor and chair of psychiatry at the University of Fribourg, Switzerland, where he is currently a practicing psychiatrist specializing in psychedelic-assisted psychotherapy and head of the Psychiatry Research Department at the University of Fribourg where he supervises researchers in psychiatric and psychedelic research. He is also the author of five books and more than 100 peer-reviewed scientific papers, for which he has received numerous awards, including the NARSAD Independent Investigator Award and the Robert Bing Award of the Swiss Academy of Medical Sciences. As President of the Swiss Society for Bipolar Disorders and the Swiss Society of Pharmacovigilance in Psychiatry and as the Secretary of the Affective Disorders Section of the World Psychiatric Association, he has been organizing scientific conferences, educational courses and advanced training for many years.